Navigation Links
Nile Therapeutics to Announce 2007 Fourth Quarter and Full Year Financial Results on Thursday, March 13, 2008
Date:3/11/2008

95 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, outlook, milestones, the success of Nile's product development, future financial position, future financial results, plans and objectives of management are forward-looking statements. We may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various important factors that could cause actual results or events to differ materially from the forward-looking statements that we make are described in greater detail in the reports we file with Securities and Exchange Commission, including the "Risk Factors" section of our Prospectus filed pursuant to Rule 424(b)(3) of the Securities Act of 1933, as amended, with the Securities and Exchange Commission on November 15, 2007. Nile is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.


'/>"/>
SOURCE Nile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
2. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
3. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
4. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
5. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
6. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13
7. ExonHit Therapeutics - 2007 Financial Results
8. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
9. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
10. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
11. CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Houston, TX (PRWEB) January 15, 2014 ... Alzheimer’s disease, and about 1 in 3 seniors will ... ( source ). These jaw-dropping figures have shocked many ... function and, hopefully, help prevent these tragic age-related cognitive ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Freeslate, ... solutions, today announced that Lupin Limited, one of India’s ... CM Protégé PharmD System for high throughput ... India, is focused on a wide range of quality, ...
(Date:1/14/2014)... 14, 2014 Histogen, Inc., a regenerative ... cells grown under simulated embryonic conditions, today announced that ... Suneva Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s ... This agreement is an amendment to the existing license ...
(Date:1/14/2014)... and BETHESDA, Md. , Jan. ... together with two institutes from the National Institutes of ... for bringing safer, more effective treatments to patients on ... Center for Advancing Translational Sciences (NCATS) and the National ...
Breaking Biology Technology:Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... BEIJING, Feb. 9 /PRNewswire-Asia-FirstCall/ -- Yongye Biotechnology,International, Inc. ... a,leading developer, producer and distributor of nutrients for ... China, today announced that the,Company,s management will present ... Conference in Dana Point, California. , ...
... 9 ,Shire plc (LSE: SHP, NASDAQ: SHPGY ), the ... 19 February 2009. , , Results press release ... EST, Investor meeting and conference call time: ... & Analyst meeting and conference call: , ...
... CLEVELAND A recent discovery at Case Western Reserve ... fresher longer and electronic equipment dryer and more secure ... , The finding involves a nanotechnology-based technique to block ... it stronger while using less material. It was made ...
Cached Biology Technology:Yongye Biotechnology to Present at Roth Conference 2Yongye Biotechnology to Present at Roth Conference 3Full Year 2008 Results Date Notification - 19 February 2008 2Accidental discovery has potential for new applications in packaging 2
(Date:4/23/2014)... one can argue that if we were to follow a ... we canthen we can solve the climate problem without doing ... climate researchers, in the current issue of Bulletin of ... significant action on climate change now makes it more likely ... Wigley explains in an exclusive Bulletin interview. ...
(Date:4/22/2014)... There are all sorts of signaling strategies in nature. ... tails; satin bowbirds build specialized stick structures, called bowers, ... European bitterling males show off bright nuptial coloration during ... to communicate with others. , ... profound fitness implications for individuals that are either signaling ...
(Date:4/22/2014)... the University of Montana,s Wildlife Biology Program, co-wrote a research ... National Academy of Sciences on how streamwater chemistry varies ... Lowe and ... of Washington, the Cary Institute of Ecosystem Studies, the University ... examined 664 water samples collected every 10 meters along 32 ...
Breaking Biology News(10 mins):Is nuclear power the only way to avoid geoengineering? 2Best practices in communication for the animal world 2Best practices in communication for the animal world 3New research focuses on streamwater chemistry, landscape variation 2
... blood and marrow transplant physician Naynesh Kamani, ... a new national clinical trial of unrelated donor marrow ... sickle cell disease . Children,s National will join more ... II clinical trial of this treatment. If successful, the ...
... the "air pollution danger zone," according to new research ... researchers have found that more than 30 percent of ... quarter mile, of major highways that consistently serve as ... shown that proximity to major highwaysand thus environmental pollutants, ...
... bees industriously bring pollen and nectar to the hive, ... of pesticides, according to Penn State researchers. Add the ... structure of the hive, and bee researchers see a ... approach may mitigate at least some beeswax contamination. ...
Cached Biology News:Children's national co-leads nationwide study of landmark sickle cell treatment 2Many US public schools in 'air pollution danger zone' 2Many US public schools in 'air pollution danger zone' 3Pesticide build-up could lead to poor honey bee health 2Pesticide build-up could lead to poor honey bee health 3Pesticide build-up could lead to poor honey bee health 4
... multiple tissue panels are designed for ... genes or proteins of interest in ... on positively charged glass slides. Total ... the identical format, and cDNA from ...
XA7 B6...
... Kit is optimized for the ... of ready-to-use dsRNA for RNAi ... MEGAscript RNAi Kit is based ... technol-ogy and includes reagents for ...
... its actuators as building blocks, Parker ... cell-level ,robotic solutions that are ideal ... the base ,system, Parker can also ... custom structures, and ,guarding., Standard ...
Biology Products: